Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR‐Cas9
Drug Development Research · 2025
DOI: 10.1002/ddr.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Yujie Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: This work was supported by the Nantong Social Science and Technology Plan for People's Livelihood Project (grant No. JCZ2023003) from the Science and Technolog….
Abstract (Originalsprache)
Ovarian cancer is the seventh most common lethal tumor among women in the world. FOXM1 is a transcription factor implicated in the initiation and progression of ovarian cancer by regulating key oncogenic genes. The role of regulatory regions in regulating the expression of FOXM1 in ovarian cancer is not completely clarified. Treatment with bromodomain and extraterminal (BET) inhibitors JQ‐1 and I‐BET were explored in ovarian cancer cell lines (OVCAR3, A2780, or SKOV3) to evaluate FOXM1 expression and biological behavior by qPCR, CCK8 assay, colony formation assay, wound‐healing, and transwell assays. The regulatory regions (enhancer sequence spanning promoter or exon 1) of FOXM1 were deleted using CRISPR‐Cas9 in the OVCAR3 cell line. FOXM1 expression and tumor biological behavior were further assessed in FOXM1 regulatory regions deleted OVCAR3 cell line. The mouse xenograft model was assessed at the indicated time points following subcutaneous injection of enhancer‐deleted cells. Treatment with the JQ‐1 and I‐BET reduced the expression of FOXM1, decreasing cell proliferation, migration, and invasion in a panel of ovarian cancer cell lines including OVCAR3, A2780, and SKOV3 cells. By mining the published ChIP‐sequencing data (H3K27Ac) from 12 ovarian cancer cell lines, we identified a potential enhancer and promoter region. Deletion of the spanning enhancer and promoter region of FOXM1 reduced mRNA and protein expression. Similarly, cell proliferation, migration, invasion, and tumorigenesis in both cells and mouse xenograft models were significantly attenuated. Our study demonstrates that JQ‐1 and I‐BET can regulate the expression of the FOXM1 gene‐relating network. These data also indicate that disruption of the span enhancer and promoter region activity of FOXM1 has a vital role in the anti‐ovarian cancer effect, hiding a potential opportunity for the evaluation of this non‐coding DNA deletion disrupts the FOXM1 transcriptional network in ovarian cancer development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Nantong, China.
- Department of Oncology, Huaian Hospital of Huaian City, Huaian, China.
- Department of Rehabilitation Medicine, The First People's Hospital of Nantong, Nantong, China.
ORCID-Profile: Yujie Chen
Förderung
- This work was supported by the Nantong Social Science and Technology Plan for People's Livelihood Project (grant No. JCZ2023003) from the Science and Technolog…
Zitieren
APA
Chen, Y., Xue, Y., Jiang, Q., Jin, Y., Chen, W., & Hua, M. (2025). Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR‐Cas9. Drug Development Research. https://doi.org/10.1002/ddr.70049
Vancouver
Chen Y, Xue Y, Jiang Q, Jin Y, Chen W, Hua M. Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR‐Cas9. Drug Development Research. 2025. doi:10.1002/ddr.70049
BibTeX
@article{Chen2025,
author = {Chen, Yujie and Xue, Yingzhuo and Jiang, Qiuwen and Jin, Yunfeng and Chen, Weiguan and Hua, Minhui},
title = {Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR‐Cas9},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70049}
}
EUVIMED